Clinical proteomics: current status, challenges, and future perspectives

Shyh-Horng Chiou1, Chi-Yue Wu

  • 1Graduate Institute of Medicine and Center for Research Resources and Development, Kaohsiung Medical University, Kaohsiung, Taiwan. shchiou@kmu.edu.tw

Summary

Mass spectrometry (MS)-based proteomics offers powerful tools for analyzing protein expression. This review covers advanced MS platforms and techniques for clinical researchers in the postgenomic era.